Question follow-through · 6694

General Practitioners: Contracts

To ask the Secretary of State for Health and Social Care, whether his Department has held discussions with the Care Quality Commission on the potential impact of the policy on GPs’ use of advice and guidance on (a) GP indemnity and (b) patient safety.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
3 Jun 2026
Target answer date
8 Jun 2026
Answer
18 Jun 2026 · 15 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 3 Jun 2026

    Question tabled

    To ask the Secretary of State for Health and Social Care, whether his Department has held discussions with the Care Quality Commission on the potential impact of the policy on GPs’ use of advice and guidance on (a) GP indemnity and (b) patient safety.

  2. 8 Jun 2026

    Target answer date

    Date supplied by the official written-questions record.

  3. 18 Jun 2026

    Answer published

    The Department and NHS England considered the potential impacts of expanding Advice and Guidance (A&G) as part of the policy development process, including through clinical input, established governance arrangements, and equalities considerations. A&a...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Health Services: Standards

4 Jun 2026 · To ask the Secretary of State for Health and Social Care, if he will list the integrated care boards that have implemented policies involving minimum waiting times for NHS treatment.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Health Services: Standards

4 Jun 2026 · To ask the Secretary of State for Health and Social Care, for which procedures, treatments or clinical pathways minimum waiting times have been applied by Integrated Care Boards; and what criteria are used to determine their application.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Health Services: Standards

4 Jun 2026 · To ask the Secretary of State for Health and Social Care, what guidance NHS England has issued to Integrated Care Boards on the use of minimum waiting times; and whether prior approval is required before such policies are implemented.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Health Services: Standards

4 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the compatibility of minimum waiting time policies with the NHS Constitution for England, including patients’ rights to access services within maximum wai

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Health Services: Standards

4 Jun 2026 · To ask the Secretary of State for Health and Social Care, what data is held by NHS England on the use and impact of minimum waiting time policies across Integrated Care Boards; and whether this information is collected centrally.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Steroid Drugs: Young People

11 Jun 2026 · To ask the Secretary of State for Health and Social Care, pursuant to WPQs 2849, 2850 and 2851 answered on 9 June 2026 about Steroid Drugs: Young People, if he will have discussions with UK Anti Doping on the findings of their 2026 Clean Sport Survey on t

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Steroid Drugs: Young People

11 Jun 2026 · To ask the Secretary of State for Health and Social Care, pursuant to WPQs 2849, 2850 and 2851 answered on 9 June 2026 about Steroid Drugs: Young People, if he will have discussions with the Secretary of State for Science, Innovation and Technology on con

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Steroid Drugs: Young People

11 Jun 2026 · To ask the Secretary of State for Health and Social Care, pursuant to WPQs 2849, 2850 and 2851 answered on 9 June 2026 about Steroid Drugs: Young People, if he will ensure that issues surrounding Anabolic Steroids, IPEDs and SARMs are included in work to

Unreviewed candidateSame MP and department; topic relationship is unreviewed

General Practitioners: Finance

18 Jun 2026 · To ask the Secretary of State for Health and Social Care, when he expects the National Institute for Health and Care Research to publish findings from phase one of the Carr-Hill review.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

General Practitioners: Finance

18 Jun 2026 · To ask the Secretary of State for Health and Social Care, what the planned timetable is for the complete conclusion of the review of the Carr-Hill formula, and the publication of its findings.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Leukaemia: Diagnosis

30 Jun 2026 · To ask the Secretary of State for Health and Social Care, what recent steps he has taken to support the national rollout of the Leukaemia Best Practice Timed Pathway.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Steroid Drugs

30 Jun 2026 · To ask the Secretary of State for Health and Social Care, if he will hold discussions with (a) local and national health bodies, (b) academics and (c) the Men's Health Strategy Stakeholder Group on the issues surrounding Anabolic Steroids, IPEDs and SARMS